Network pharmacology analysis revealed that EMP exerts its therapeutic effects on HUA‐CI through multi‐target and multi‐pathway mechanisms, particularly emphasizing the strong binding affinity between AF and MAP2K1. This evidence concerns the gene MAEA and atrial fibrillation.